The Present and FutureState-of-the-Art ReviewTestosterone and Cardiovascular Disease
State-of-the-Art Review
Under an Elsevier user license
open archive
Key Words
angina
heart failure
hormone replacement therapy
major adverse cardiovascular events
male health
myocardial infarction
Abbreviations and Acronyms
6MWT
6-min walk test
ADT
androgen deprivation therapy
CI
confidence interval
CV
cardiovascular
DHT
dihydrotestosterone
ECG
electrocardiogram
ED
erectile dysfunction
FDA
Food and Drug Administration
FSH
follicle-stimulating hormone
GnRH
gonadotropin-releasing hormone
HF
heart failure
LH
luteinizing hormone
MI
myocardial infarction
SHBG
sex hormone-binding globulin
T
testosterone
TRT
testosterone replacement therapy
Vo2
peak oxygen consumption
Cited by (0)
Dr. Kloner is a consultant to Abbvie and Teso-Rx. Dr. Carson is a consultant for Abbvie, Boston Scientific, and ENDO. Dr. Dobs serves on the advisory board for Abbvie. Dr. Kopecky is a consultant for Prime Therapeutics. Dr. Mohler is a consultant for Clarus and Abbvie.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.